✦ LIBER ✦

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

✍ Scribed by Stefania Redana; Michela Donadio; Franco Nolè; Maria Elena Jacomuzzi; Alessandra Beano; Rossella Martinello; Anna Sapino; Giuseppe Viale; Massimo Aglietta; Filippo Montemurro

Book ID: 115010063
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 309 KB
Volume: 10
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-10-28

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Weekly Docetaxel, Vino

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Jeffrey R. Infante; Denise A. Yardley; Howard A. Burris III; F. Anthony Greco; C 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

Trastuzumab plus docetaxel with or witho

Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study

✍ A. Wardlev; A. Anton-Torres; X. Pivot; F. Morales-Vasquez; L. Zetina; M. de Fati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

8N Similar outcome in a randomized phase

✍ M. Andersson; E. Lidbrink; E. Wist; K. Enevoldsen; A.B. Jensen; P.G. Sørensen; K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A phase I/II trial of non-pegylated lipo

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

An exploratory study of sunitinib in com

An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer

✍ Fatima Cardoso; Jean-Luc Canon; Dino Amadori; Daniela Aldrighetti; Jean-Pascal M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Phase II Multicenter Study of Docetaxel

Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer

✍ Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H. 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB